FDA Investigator Patrick R Dimapindan
Patrick R Dimapindan has inspections in 1 countries as of 30 Aug 2023. Patrick R Dimapindan has collaborated with a combined 1133 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
30 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alejandra Mcclellan,
Alexandra B Pitkin,
Ana Djurdjevic,
Anthony E Guzman,
Burnsb,
Carr Sharpe,
Cathryn M Groehnert,
Christopher J Stannard,
Comyar Shoghi,
Cristina E Mosquera,
Daniel J Simonsen,
Danielle M Didonna,
Darrin E Davis,
David Serrano,
Deborah L Parker,
Debra J Fracassa,
Dennis N Hoang,
Desiree C Iya,
Devon O Seymour,
Diane R Weidley,
Eileen T Dupont,
Elizabeth M Dahl,
Elsa A Kusumoto,
Erik D Sandvig,
Fe Q Reyes,
Francisco,
Gordon Chu,
Henry E Carrillo,
Herminio C Francisco,
Hoover,
Jake T Lane,
James A Barreto,
Jeannie Pradyanata,
Jessica L Andrade,
Jinnie Kokiatkulkij,
John A Liu,
John R Myung,
Joseph C Francisco,
Joseph H Lam,
Judy C Nepsa,
Kai Wang,
Karen L Bauer,
Katherine P Tran,
Keeshunna D Daniels,
Kevin Lee,
Kham Phommachanh,
Kimberly M Lichter,
Lacresha Menifee,
Lilly O Barton,
Marco A Solorio,
Mario A Iglesias,
Mark C Saale,
Mark Gray,
Michael J Chan,
Natalie J Ayoub,
Nicholas J Lahey,
Pamela Y Lee,
Patricia F Alberico,
Phillip L Toy,
Richard G Fochesato,
Ryan J Borges,
Sandersk,
Sarah R Barker,
Sean P Desbrow,
State Agency,
Sundy V Sedwick,
Terrance P Nguyen,
Tomanik'e C Banks,
Victoria C Yang
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more